NVCT: Nuvectis Pharma, Inc. Stock

by  •  • Comments Off on NVCT: Nuvectis Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 108.97
Enterprise Value ($M) 91.80
Book Value ($M) 10.99
Book Value / Share 0.57
Price / Book 9.91
NCAV ($M) 10.99
NCAV / Share 0.57
Price / NCAV 9.91

Profitability (mra)
Return on Invested Capital (ROIC) -1.76
Return on Assets (ROA) -1.01
Return on Equity (ROE) -1.59

Liquidity (mrq)
Quick Ratio 2.74
Current Ratio 2.74

Balance Sheet (mrq) ($M)
Current Assets 17.31
Assets 17.31
Liabilities 6.32
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-05 13G/A Pontifax Management 4 G.p. (2015) Ltd. 1.50 -68.51
02-28 13G/A Mosseri Marlio Charles 15.00 9.03
02-01 13G/A Shemesh Shay 8.60 23.72
02-01 13G/A Poradosu Enrique 8.70 23.43
01-31 13G/A Peters Thomas Phineas 5.20 -4.13

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-05 10-Q On the Microsoft license do we have access to UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 13,956 81,231 17.18
2025-01-14 10,428 32,818 31.78
2025-01-13 29,119 117,179 24.85
2025-01-10 15,551 67,207 23.14

(click for more detail)

Similar Companies
NLSP – NLS Pharmaceutics AG NRSN – NeuroSense Therapeutics Ltd.
NRXP – NRx Pharmaceuticals, Inc. OCEA – Ocean Biomedical, Inc.
OCGN – Ocugen, Inc.


Financial data and stock pages provided by
Fintel.io